Cargando…

Prolonged excretion of type-2 poliovirus from a primary immune deficient patient during the transition to a type-2 poliovirus-free world, Israel, 2016

Wild poliovirus type-2 has been eradicated, use of live type-2 vaccine has been terminated globally, and all type-2 polioviruses are under strict laboratory containment protocols. Re-emergence may arise from prolonged asymptomatic excretion of poliovirus by hospitalised primary immune deficient (PID...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weil, Merav, Shulman, Lester M, Heiman, Sophia, Stauber, Tali, Alfandari, Jacqueline, Weiss, Leah, Silberstein, Ilana, Indenbaum, Viki, Mendelson, Ella, Sofer, Danit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2016
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291147/ https://www.ncbi.nlm.nih.gov/pubmed/27918258 http://dx.doi.org/10.2807/1560-7917.ES.2016.21.47.30408

Ejemplares similares

Epidemiology of Type 3 Poliovirus AFP Cases in Israel between 1973 and 1988: Whole Genome Sequencing of RNA Extracted Directly from Archived Stocks to Avoid Re-Culturing Neurovirulent Wild Poliovirus
por: Shulman, Lester M., et al.
Publicado: (2022)

Emergence of genetically linked vaccine-originated poliovirus type 2 in the absence of oral polio vaccine, Jerusalem, April to July 2022
por: Zuckerman, Neta S, et al.
Publicado: (2022)

Neurovirulent Vaccine-Derived Polioviruses in Sewage from Highly Immune Populations
por: Shulman, Lester M., et al.
Publicado: (2006)

Ongoing mumps outbreak in Israel, January to August 2017
por: Indenbaum, Viki, et al.
Publicado: (2017)

Antiviral Activity of 3(2H)- and 6-Chloro-3(2H)-Isoflavenes against Highly Diverged, Neurovirulent Vaccine-Derived, Type2 Poliovirus Sewage Isolates
por: Shulman, Lester M., et al.
Publicado: (2011)

Inferring Numbers of Wild Poliovirus Excretors Using Quantitative Environmental Surveillance
por: Perepliotchikov, Yuri, et al.
Publicado: (2021)

Increased detection of Echovirus 6-associated meningitis in patients hospitalized during the COVID-19 pandemic, Israel 2021–2022
por: Fratty, Ilana S., et al.
Publicado: (2023)

Wild poliovirus type 3 (WPV3)-shedding event following detection in environmental surveillance of poliovirus essential facilities, the Netherlands, November 2022 to January 2023
por: Duizer, Erwin, et al.
Publicado: (2023)

Genotyping Rotavirus RNA from Archived Rotavirus-Positive Rapid Test Strips
por: Shulman, Lester M., et al.
Publicado: (2011)

The dynamics of infection and the persistence of immunity to A(H1N1)pdm09 virus in Israel
por: Weil, Merav, et al.
Publicado: (2012)

Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India
por: Mohanty, Madhu Chhanda, et al.
Publicado: (2017)

Epidemiologic and phylogenetic analysis of the 2018 West Nile virus (WNV) outbreak in Israel demonstrates human infection of WNV lineage I
por: Lustig, Yaniv, et al.
Publicado: (2019)

Under-diagnosis of SARS-CoV-2 infections among children aged 0–15 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021
por: Indenbaum, Victoria, et al.
Publicado: (2021)

Detection of SARS-CoV-2 variants by genomic analysis of wastewater samples in Israel
por: Bar-Or, Itay, et al.
Publicado: (2021)

Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?
por: Resik, Sonia, et al.
Publicado: (2018)

Lessons from Vaccine-Related Poliovirus in Israel, UK and USA
por: John, T. Jacob, et al.
Publicado: (2022)

Response to a wild poliovirus type 2 (WPV2)-shedding event following accidental exposure to WPV2, the Netherlands, April 2017
por: Duizer, Erwin, et al.
Publicado: (2017)

An imported case of vaccine-derived poliovirus type 2, Spain in the context of the ongoing polio Public Health Emergency of International Concern, September 2021
por: Chirlaque López, María Dolores, et al.
Publicado: (2021)

Notes from the Field: Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use — Six African Countries, 2021–2023
por: Davlantes, Elizabeth, et al.
Publicado: (2023)

Monitoring of Enterovirus D68 Outbreak in Israel by a Parallel Clinical and Wastewater Based Surveillance
por: Erster, Oran, et al.
Publicado: (2022)

Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal()
por: Harutyunyan, Vachagan, et al.
Publicado: (2023)

Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians’ perspectives in the endgame plan for polio eradication
por: Galal, Nermeen M., et al.
Publicado: (2018)

The re-emergence of wild poliovirus type 1 in Africa and the role of environmental surveillance in interrupting poliovirus transmission
por: Gwinji, Phanuel Tawanda, et al.
Publicado: (2022)

National Scale Real-Time Surveillance of SARS-CoV-2 Variants Dynamics by Wastewater Monitoring in Israel
por: Bar-Or, Itay, et al.
Publicado: (2022)

STUDIES OF THE FATE OF TYPE 1 POLIOVIRUSES IN FLIES
por: Gudnadóttir, Margrét G.
Publicado: (1961)

Direct detection of polioviruses using a recombinant poliovirus receptor
por: Gerloff, Nancy, et al.
Publicado: (2021)

Virologic Monitoring of Poliovirus Type 2 after Oral Poliovirus Vaccine Type 2 Withdrawal in April 2016 — Worldwide, 2016–2017
por: Diop, Ousmane M., et al.
Publicado: (2017)

Emergence of vaccine-derived poliovirus type 2 after using monovalent type 2 oral poliovirus vaccine in an outbreak response, Philippines
por: Alipon, SweetC B, et al.
Publicado: (2022)

Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies
por: Resik, Sonia, et al.
Publicado: (2015)

The effect of maternal poliovirus antibodies on the immune responses of infants to poliovirus vaccines
por: Jia, Siyue, et al.
Publicado: (2020)

Wild Poliovirus Type 1, Central African Republic
por: Gouandjika-Vasilache, Ionela, et al.
Publicado: (2005)

Evaluation of Four Different Systems for Extraction of RNA from Stool Suspensions Using MS-2 Coliphage as an Exogenous Control for RT-PCR Inhibition
por: Shulman, Lester M., et al.
Publicado: (2012)

Mucosal immunity to poliovirus
por: Connor, Ruth I., et al.
Publicado: (2021)

Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria
por: Iliyasu, Zubairu, et al.
Publicado: (2016)

Nearly Complete Genome Sequences of Type 2 Sabin-Like Polioviruses from Northern Nigerian Poliovirus Surveillance, 2016 to 2018
por: Zhao, Kun, et al.
Publicado: (2022)

Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks()
por: Estivariz, Concepcion F., et al.
Publicado: (2023)

Deficiency of immunity to poliovirus type 3: a lurking danger?
por: Reinheimer, Claudia, et al.
Publicado: (2012)

Increasing Type 1 Poliovirus Capsid Stability by Thermal Selection
por: Adeyemi, Oluwapelumi O., et al.
Publicado: (2017)

Progress Toward Containment of Poliovirus Type 2 — Worldwide, 2017
por: Previsani, Nicoletta, et al.
Publicado: (2017)

Possible Eradication of Wild Poliovirus Type 3 — Worldwide, 2012
por: Kew, Olen M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fektlmpdbckq8touv6badno5pk